Webinars

Search

Saved Activities

 x 

0 Activities
0 Activities

Ulcerative Colitis: What Can You Expect When a Patient is Switched to a Biosimilar?

Array

Activity Info

Upon completion of the activity, participants should be able to explain what could – or could not – occur when a patient who is well controlled on a biologic originator is switched to a biosimilar.
Email

CME/CE credit is no longer available for this activity.

Tags

Webinar | 0.50 - 30 mins | Gastroenterology | Internal Medicine | Family Medicine | Nurse | Biosimilars | BiosimilarsCME.org | Online | Pharmacist |